Identification of miRNAs, mRNAs, lncRNAs, and circRNAs associated with hepatocellular carcinoma recurrence after interferon treatment.

Identification of miRNAs, mRNAs, lncRNAs, and circRNAs associated with hepatocellular carcinoma recurrence after interferon treatment.
复制标题

干扰素治疗后与肝细胞癌复发相关的 miRNA、mRNA、lncRNA 和 circRNA 的鉴定。

DOI:
10.23812/21-173-a
复制
发表时间:
2021-07
期刊:
J Biol Regul Homeost Agents
影响因子:
--
通讯作者:
Lu Wang
Lu Wang
中科院分区:
其他
文献类型:
--
作者:
Weiping Zhu;Xigan He;Hongxu Zhu;Lingli Wang;Zhenhai Lin;Miao Wang;Lu Wang

文献摘要

相似文献

为了研究干扰素-α(IFN-α)治疗肝细胞癌(HCC)的分子机制和预测疗效的分子标志物,从4例未接受治疗的HCC患者(对照组)的12个样本中筛选差异表达(DE)-miRNAs、-mRNAs、-lncRNAs和-circRNAs,4例接受过重组人干扰素a-2b治疗(病例1),4例接受重组人干扰素a-2b治疗后复发(病例2)。进行富集分析以确定DE-RNA的主要功能。我们还构建了蛋白质-蛋白质相互作用(PPI)和竞争性内源RNA(ceRNA)网络。此外,进行了系列聚类分析,以分析不同HCC组间基因表达的变化。此外,这些基因的表达在癌症基因组图谱(TCGA)数据库中得到了验证。在对照组与病例1组以及病例2组与病例1组之间,共获得36个联合DE-miRNAs、175个联合DE-mRNAs、65个联合DE-lncRNAs和52个联合DE-circRNAs。DE-mRNA主要表达于线粒体内膜。DE-circRNA主要富集在高尔基体中。ceRNA网络包含68个DE-mRNA、26个DE-miRNA、45个DE-lncRNA和23个DE-circRNA。共24个DE-miRNAs、175个DE-mRNAs、65个DE-lncRNAs和52个DE-circRNAs分别被分为8个谱。与肝癌预后显著相关的基因有26个(p < 0.05)。某些基因可用于预测IFN-α治疗HCC的疗效。本研究结果为进一步探讨IFN-α治疗肝癌的敏感性差异奠定了基础。
To study the molecular mechanism of interferon-alpha (IFN-α) in the treatment of hepatocellular carcinoma (HCC) and the molecular markers that can predict the therapeutic effect, differentially expressed (DE)-miRNAs, -mRNAs, -lncRNAs, and -circRNAs were screened between 12 samples collected from 4 patients who had not received treatment (control), 4 patients who had received recombinant human interferon a-2b treatment (case1), and 4 patients who had relapsed after receiving recombinant human interferon a-2b treatment (case2). Enrichment analyses were performed to determine the principal functions of the DE-RNAs. We also constructed protein-protein interactions (PPI) and competing endogenous RNA (ceRNA) networks. In addition, a series-cluster analysis was performed to analyze changes in gene expression across different groups of HCC. Furthermore, the expression of the genes were verified in the Cancer Genome Atlas (TCGA) database. A total of 36 union DE-miRNAs, 175 union DE-mRNAs, 65 union DE-lncRNAs, and 52 union DE-circRNAs were obtained between the control vs case1, and case2 vs case1 groups. DE-mRNAs were mainly involved in the mitochondrial inner membrane. DE-circRNAs were mainly enriched in the Golgi apparatus. ceRNA network contained 68 DE-mRNAs, 26 DE-miRNAs, 45 DE-lncRNAs, and 23 DE-circRNAs. A total of 24 DE-miRNAs, 175 DE-mRNAs, 65 DE-lncRNAs, and 52 DE-circRNAs were classified into eight profiles, respectively. A total of 26 genes showed a significant correlation with prognosis of HCC (p < 0.05). Some genes may be used to predict the efficacy of IFN-α in the treatment of HCC. The results may lay a foundation for investigating the different sensitivities of IFN-α in the treatment of HCC.